BHVN Biohaven Ltd.
$15.29▲ +5.81%
Healthcare
Other
Pre-market
$14.91▼ -2.46%
Oct 28, 5:39 AM ET
Volume 2.43M
Avg Volume (10D) 5.06M
Key Metrics & Fundamentals
Market Cap
$2.31B
P/E Ratio
–
Div Yield
0.00%
52W Range
7.48 - 18.57
% vs 50 MA
13.27%
% vs 200 MA
25.72%
RSI-14
64.3
MACD Histogram
+0.4700
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$85.55M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$122.64M
COGS
–
Operating Exp
$124.90M
Operating Income
-$124.90M
EBIT
-$124.90M
Pretax Income
-$136.92M
Net Income
-$137.31M
EPS (Diluted)
-0.91
Price & Volume History
Loading chart…
Recent News
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
PR Newswire · Oct 26, 2026 10:31 AM ET
Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy
PR Newswire · Oct 26, 2026 7:30 AM ET
Biohaven Could Transform With Troriluzole's FDA Approval, RBC Says
MT Newswires · Oct 23, 2026 11:56 AM ET
Deutsche Bank Adjusts Biohaven Price Target to $26 From $20, Maintains Buy Rating
MT Newswires · Oct 23, 2026 8:06 AM ET
Why Biohaven (BHVN) Is Up 25.0% And What's Next After FDA Review Acceptance
Simply Wall St. · Oct 23, 2026 7:18 AM ET
RBC Raises Price Target on Biohaven to $22 From $19, Keeps Sector Perform, Speculative Risk
MT Newswires · Oct 23, 2026 6:50 AM ET
Biohaven (BHVN) Soars 25% on FDA Drug Review, Price Target Upgrade
Insider Monkey · Oct 22, 2026 10:28 PM ET
Why Biohaven Catapulted 25% — And Why It Might Not Be Done Sprinting
Investor's Business Daily · Oct 22, 2026 4:23 PM ET
Biohaven Shares Rise After FDA Accepts Vyglxia Resubmission for Review
MT Newswires · Oct 22, 2026 3:30 PM ET
Biohaven Stock Heads for Best Day in 3 Years as FDA Agrees to Review Drug Again
Barrons.com · Oct 22, 2026 1:29 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BHVN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.